HST Global (HSTC) Stock Price, News & Analysis

Company Overview

HST Global, Inc., operates as an integrated health and wellness biotechnology company in the United States. The company develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer and other life threatening diseases. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancer and or/ life threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.

Key Stats

• Today's Range: $0.0002 to $0.0002
• 50-Day Range: $0.00 to $0.42
• 52-Week Range: $0.00 to $1.05
• Volume: N/A
• Average Volume: 35 shs
• Market Capitalization: $14.04 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HSTC Stock Analysis - Frequently Asked Questions

How have HSTC shares performed this year?

HST Global's stock was trading at $0.85 at the beginning of the year. Since then, HSTC stock has decreased by 100.0% and is now trading at $0.0002.

How were HST Global's earnings last quarter?

HST Global Inc. (OTCMKTS:HSTC) released its earnings results on Monday, November, 20th. The company reported $0.00 earnings per share for the quarter.

How do I buy shares of HST Global?

Shares of HSTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of HST Global own?

Based on aggregate information from My MarketBeat watchlists, some other companies that HST Global investors own include Amplify CWP Enhanced Dividend Income ETF (DIVO), Amplify Lithium & Battery Technology ETF (BATT), Ascent Solar Technologies (ASTI), Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR), Arch Therapeutics (ARTH), Amerigo Resources (ARREF) and Blue Apron (APRN).

Company Calendar

• Last Earnings: 11/20/2017
• Today: 8/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:HSTC
• CIK: 797564
• Web: www.hstglobal.com
• Phone: (757) 766-6100
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 70,188,000
• Free Float: 23,990,000
• Market Cap: $14.04 thousand
• Optionable: Not Optionable
• Beta: -1.49